FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population;Umbrales de FRAX® para identificar personas con alto o bajo riesgo de fractura osteoporótica en población femenina española

Medicina Clinica

Volumn 144, Issue 1, 2015, Pages 1-8

  Azagra, Rafael ^a,b,c   Roca, Genís ^a,b   Martín Sánchez, Juan Carlos ^c   Casado, Enrique ^d   Encabo, Gloria ^e   Zwart, Marta ^a,f   Aguyé, Amada ^g   Díez Pérez, Adolf ^a,h,i  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Medicina de Familia   (Spain)

^c UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

^d HOSPITAL DE SABADELL   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f Medicina de Familia y Comunitaria   (Spain)

^g INSTITUT CATALÀ DE LA SALUT   (Spain)

^h INST MUNIC D INVESTIGACIO MEDICA   (Spain)

ⁱ INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cost effectiveness; Dual energy X ray absorptiometry; FRAX ; Osteoporosis; Osteoporotic fracture

Indexed keywords

BONE DENSITY CONSERVATION AGENT; CALCIUM; VITAMIN D;

ADULT; ADVERSE EFFECTS; AGED; BODY MASS; BONE DENSITY; COMPLICATION; COST BENEFIT ANALYSIS; DRINKING BEHAVIOR; FEMALE; FRACTURES, SPONTANEOUS; HUMAN; MIDDLE AGED; ONLINE SYSTEM; OSTEOPOROSIS; PATIENT SELECTION; PHOTON ABSORPTIOMETRY; PROCEDURES; PROSPECTIVE STUDY; RADIOGRAPHY; RISK; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SMOKING; SPAIN; VERY ELDERLY;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BODY MASS INDEX; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CALCIUM; COST-BENEFIT ANALYSIS; FEMALE; FRACTURES, SPONTANEOUS; HUMANS; MIDDLE AGED; ONLINE SYSTEMS; OSTEOPOROSIS; PATIENT SELECTION; PROSPECTIVE STUDIES; RISK; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SPAIN; VITAMIN D;

EID: 84918574095     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2013.11.014     Document Type: Article

References (29)

1. C. Holroyd, C. Cooper, and E. Dennison Epidemiology of osteoporosis Best Pract Res Clin Endocrinol Metab 22 2008 671 685
2. K.M. Huntjens, S. Kosar, T.A. van Geel, P.P. Geusens, P. Willems, and A. Kessels Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture Osteoporos Int 21 2010 2075 2082
3. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group World Health Organ Tech Rep Ser 843 1994 1 129
4. D. Marshall, O. Johnell, and H. Wedel Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures BMJ 312 1996 1254 1259
5. J.P. Van den Bergh, T.A. van Geel, W.F. Lems, and P.P. Geusens Assessment of individual fracture risk: FRAX and beyond Curr Osteoporos Rep 8 2010 131 137
6. J. Kanis on behalf of the World Health Organization Scientific Group Assessment of osteoporosis at the primary health-care level. Technical Report 2007 WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Sheffield, United Kingdom Disponible en: http://www.shef.ac.uk/FRAX/pdfs/WHO-Technical-Report.pdf. Consultado el 27/12/2013
7. N.D. Nguyen, S.A. Frost, J.R. Center, J.A. Eisman, and T.V. Nguyen Development of a nomogram for individualizing hip fracture risk in men and women Osteoporos Int 18 2007 1109 1117
8. J. Hippisley-Cox, and C. Coupland Predicting risk of osteoporotic fracture in men and women in England and Wales: Prospective derivation and validation of QFractureScores BMJ 339 2009 b4229
9. J.A. Kanis, N. Burlet, C. Cooper, P.D. Delmas, J.Y. Reginster, and F. Borgstrom European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 19 2008 399 428
10. L.A. Fraser, L. Langsetmo, C. Berger, G. Ioannidis, D. Goltzman, and J.D. Adachi Fracture prediction and calibration of a Canadian FRAX® tool: A population-based report from CaMos Osteoporos Int 22 2011 829 837
11. A. Lalmohamed, P.M. Welsing, W.F. Lems, J.W. Jacobs, J.A. Kanis, and H. Johansson Calibration of FRAX® 3.1 to the Dutch population with data on the epidemiology of hip fractures Osteoporos Int 23 2012 861 869
12. P. Piscitelli, G. Chitano, H. Johannson, M.L. Brandi, J.A. Kanis, and D.M. Black Updated fracture incidence rates for the Italian version of FRAX® Osteoporos Int 24 2013 859 866
13. J.A. Kanis, E.V. McCloskey, H. Johansson, O. Strom, F. Borgstrom, and A. Oden Case finding for the management of osteoporosis with FRAX®-assessment and intervention thresholds for the UK Osteoporos Int 19 2008 1395 1408
14. A.N. Tosteson, L.J. Melton 3rd, B. Dawson-Hughes, S. Baim, M.J. Favus, and S. Khosla Cost-effective osteoporosis treatment thresholds: The United States perspective Osteoporos Int 19 2008 437 447
15. K. Lippuner, H. Johansson, F. Borgström, J.A. Kanis, and R. Rizzoli Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland Osteoporos Int 23 2012 2579 2589
16. J.A. Kanis, O. Johnell, C. de Laet, B. Jonsson, A. Oden, and A.K. Ogelsby International variations in hip fracture probabilities: Implications for risk assessment J Bone Miner Res 17 2002 1237 1244
17. R. Azagra, G. Roca, G. Encabo, A. Aguyé, M. Zwart, and S. Güell FRAX® tool, the WHO algorithm to predict osteoporotic fractures: The first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort BMC Musculoskelet Disord 13 2012 204
18. J. González-Macías, F. Marin, J. Vila, and A. Díez-Pérez Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort Bone 50 2012 373 377
19. C. Tebé, L.M. del Río, L. Casas, M.D. Estrada, A. Kotzeva, and S. di Gregorio Factores de riesgo de fracturas por fragilidad en una cohorte de mujeres españolas Gac Sanit 25 2011 507 512
20. R. Azagra, D. Prieto-Alhambra, G. Encabo, E. Casado, A. Aguyé, A. Díez-Pérez Grupo de estudio FRIDEX Utilidad de la herramienta FRAX® en el tratamiento de la osteoporosis en población femenina española Med Clin (Barc) 136 2011 163 169
21. W.D. Leslie, S.R. Majumdar, L.M. Lix, H. Johansson, A. Oden, E. McCloskey Manitoba Bone Density Program High fracture probability with FRAX usually indicates densitometric osteoporosis: Implications for clinical practice Osteoporos Int 23 2012 391 397
22. R. Azagra, F. López-Expósito, A. Aguyé, G. Encabo en representación del grupo GROIMAP Predicción de fracturas por fragilidad o predicción de osteoporosis densitométrica. ¡Esta es la cuestión! Med Clin (Barc) 141 2013 43 44
23. R. Azagra, M. Zwart, A. Aguyé, and G. Encabo Precauciones necesarias al utilizar los umbrales predictivos de la herramienta FRAX® en la población española para decidir la necesidad de solicitar una densitometría ósea axial Med Clin (Barc) 137 2011 713 714
24. M. Vázquez Osteoporosis: The crisis of a paradigm Med Clin (Barc) 134 2010 206 207
25. R. Azagra, G. Roca, G. Encabo, D. Prieto, A. Aguyé, and M. Zwart Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX® tool in Spain BMC Musculoskelet Disord 12 2011 30
26. W.D. Leslie, C. Berger, L. Langsetmo, L.M. Lix, J.D. Adachi, and D.A. Hanley Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: Results from the CaMos and Manitoba cohorts Osteoporos Int 22 2011 1873 1883
27. Ministerio de Ciencia e Innovación. Análisis coste-utilidad de los tratamientos farmacológicos para la prevención de fracturas en mujeres con osteoporosis en España. IPE 63/2010. Madrid: AETS-Instituto de Salud Carlos III, 2010.
28. E. Sornay-Rendu, F. Munoz, P.D. Delmas, and R.D. Chapurlat The FRAX® tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort J Bone Miner Res 25 2010 2101 2107
29. C. Escorial-Moya, M.J. Montoya-García, M.A. Vazquez-Gámez, M. Giner-García, C. Miranda-Díaz, and R. Pérez-Cano ¿Se fracturan la cadera los hombres y las mujeres ante los mismos factores de riesgo? Rev Clin Esp 211 2011 495 503